Literature DB >> 23305900

Trends in utilization and outcomes of bariatric surgery in obese people with and without type 2 diabetes in Spain (2001-2010).

Ana Lopez-de-Andres1, Rodrigo Jiménez-García, Valentin Hernández-Barrera, Angel Gil-de-Miguel, M Isabel Jiménez-Trujillo, Pilar Carrasco-Garrido.   

Abstract

AIM: Bariatric surgery is associated with a significant improvement in glucose control and even diabetes remission. There are no studies investigating national trends in the use of bariatric surgery in people with type 2 diabetes. We examine trends in the use of bariatric surgery in patients with and without type 2 diabetes between 2001 and 2010 in Spain.
METHODS: We identified patients who underwent bariatric surgery using national hospital discharge data. Discharges were grouped by diabetes status. Incidence of discharges due to bariatric surgery were calculated and stratified by diabetes status, procedure and year. We calculated length of stay (LOS) and in-hospital mortality (IHM).
RESULTS: From 2001 to 2010 13,038 bariatric surgery procedures were performed. Over the study period 23.6% (n=3080) of all patients undergoing bariatric procedure had DM as a co-diagnosis. This prevalence increased from 17.3% in 2001 to 25.5% in 2010. LOS and IHM were similar among patients with and without type 2 diabetes.
CONCLUSION: The proportion of subjects with type 2 diabetes among bariatric surgery patient has increased over time, in part due to an increase in the use of laparoscopic techniques.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23305900     DOI: 10.1016/j.diabres.2012.12.011

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  A Spanish Society joint SECO and SEEDO approach to the Post-operative management of the patients undergoing surgery for obesity.

Authors:  R Vilallonga; J L Pereira-Cunill; S Morales-Conde; I Alarcón; I Breton; E Domínguez-Adame; J V Ferrer; A Garcia Ruiz-de-Gordejuela; A Goday; A Lecube; E Martín García-Almenta; M Á Rubio; F J Tinahones; P P García-Luna
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

2.  National trends over one decade in hospitalization for acute myocardial infarction among Spanish adults with type 2 diabetes: cumulative incidence, outcomes and use of percutaneous coronary intervention.

Authors:  Ana Lopez-de-Andres; Rodrigo Jimenez-Garcia; Valentin Hernandez-Barrera; Isabel Jimenez-Trujillo; Carmen Gallardo-Pino; Angel Gil de Miguel; Pilar Carrasco-Garrido
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

3.  National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001-2011).

Authors:  Ana Lopez-de-Andres; Rodrigo Jimenez-García; Valentin Hernandez-Barrera; Napoleon Perez-Farinos; Jose M de Miguel-Yanes; Manuel Mendez-Bailon; Isabel Jimenez-Trujillo; Angel Gil de Miguel; Carmen Gallardo Pino; Pilar Carrasco-Garrido
Journal:  Cardiovasc Diabetol       Date:  2014-01-03       Impact factor: 9.951

4.  Trends in the prevalence of depression in hospitalized patients with type 2 diabetes in Spain: analysis of hospital discharge data from 2001 to 2011.

Authors:  Ana Lopez-de-Andrés; Ma Isabel Jiménez-Trujillo; Valentín Hernández-Barrera; José Ma de Miguel-Yanes; Manuel Méndez-Bailón; Napoleón Perez-Farinos; Carmen de Burgos Lunar; Juan Cárdenas-Valladolid; Miguel Ángel Salinero-Fort; Rodrigo Jiménez-García; Pilar Carrasco-Garrido
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

5.  Type 2 diabetes and postoperative pneumonia: An observational, population-based study using the Spanish Hospital Discharge Database, 2001-2015.

Authors:  Ana López-de-Andrés; Napoleon Perez-Farinos; Javier de Miguel-Díez; Valentín Hernández-Barrera; Isabel Jiménez-Trujillo; Manuel Méndez-Bailón; José M de Miguel-Yanes; Rodrigo Jiménez-García
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.